The genetic difference between CBA and C57 mice in their antibody response to the branched, multichain synthetic polypeptide, poly(tyr, glu)-poly-DL-ala--polylys, (T, G)-A--L, has been shown to be specific for the (tyrosine, glutamic acid) antigenic determinant (1) and to involve more than one genetic factor? Although this trait is polygenic, it is possible that most of the difference is due to a single major genetic factor? Whether or not this is so, the genetic difference shows a sharp specificity for the nature of the antigenic determinant on the multipolyalanyl--polylysine (A--L) backbone CBA's responding poorly to the (tyrosyl, glutamyl) peptide determinants and well to the (histidyl, glutamyl) peptide determinants, while C57's do just the opposite.
The genetic difference between CBA and C57 mice in their antibody response to the branched, multichain synthetic polypeptide, poly(tyr, glu)-poly-DL-ala--polylys, (T, G)-A--L, has been shown to be specific for the (tyrosine, glutamic acid) antigenic determinant (1) and to involve more than one genetic factor? Although this trait is polygenic, it is possible that most of the difference is due to a single major genetic factor? Whether or not this is so, the genetic difference shows a sharp specificity for the nature of the antigenic determinant on the multipolyalanyl--polylysine (A--L) backbone CBA's responding poorly to the (tyrosyl, glutamyl) peptide determinants and well to the (histidyl, glutamyl) peptide determinants, while C57's do just the opposite.
The present study was designed to explore further the chemical nature and uniformity of this determinant specificity through the use of a series of related synthetic polypeptide antigens, and to determine the type of genetic control involved in the antibody response to multipoly(histidyl, glutamyl)-poly-DLalanyl--polylysine, (H, G)-A--L. The results show that this determinant-specific control discriminates sharply between peptides of glutamic acid, tyrosine and glutamic acid, histidine and glutamic acid, and phenylalanine and glutamic acid on A--L; it does not discriminate between different preparations of polymers of the "poly(tyrosine, glutamic acid)" or "poly(histidine, ghitamic acid)" type which have been synthesized in a similar manner. In addition, the genetic control of the antibody response to (H, G)-A--L appears to be dominant and polygenic, just as it is for (T, G)-A--L.
Materials and Method
Synthetic Polypeptide Anligens.--The properties of the antigens used in this study are summarized in Table I , and further details of preparation are given in the references cited. The linear polymer poly (tyr,giu,als) 253 was prepared in a single polymerization step by Dr. Sara Fuchs. With the exception of T-G-A-L 415, all the multichain synthetic polypeptides were prepared in a similar manner by a three step synthesis. In the first step, the polyoL-lysine backbone was polymerized. In the second step, side chains of poly-DL-alunlrle were polymerized on the e-amino groups of the poly-L-lysine. In the final step, short, mixed, random sequences of different l-amino acids were added to the amino termini of these poly-nL-alanine side chains. The final result is shown schematically in Fig. 1 . T-G-A--L 415 was synthesized by adding only ghitamic acid to the poly-DL-alanine side chains, after which short stretches of tyrosine were added onto the giutamic acid amino termini in a fourth step.
Immunological Mahods.--The animals used, the method of immunization, and the method
of serum antibody determinations have all been described (1). In general, 10-16 wk old mice were given 10-800 #g of antigen in 0.06 ml complete Freund's adjuvant in the hind footpads, followed 5 wk later by a similar dose of the same antigen in 0.15 N NaC1, pH 7.0. The mice were bled 10 days after the second injection of antigen, and individual sera were tested for their ability to bind the antigen. Any deviations from this standard procedure are noted where appropriate.
In the usual procedure, 5 #1 of mouse antiserum was tested for its ability to bind 0~/~g of (T,G)-A-L 509-1~5I (1) or an approximately equlmola~ amount of any of the other antigens (labeled with ~tsI) listed in Table I , and the results are expressed as "% antigen bound." For those antigens containing tyrosine, the procedure was identical with that already described (1) using rabbit anti-mouse ~-giobulln to precipitate the mouse antigen-antibody complexes. Fla. 1. A schematic diagram of the structural pattern of the mnltichaln synthetic polypeptide antigens used in this study.
anhydride-all, (Ac)aH, (498 mc/mm, Nuclear-Chicago Corp., Des Plalnes, Ill.) by the method of Vratsanos (4) . The specific acitivity of (H,G)-A-L 1201-(Ac)SH was 6/~c/mg and this preparation was 98% bound by excess specific antibody. The specific activity of (P, G)-A-L 223-(Ac) aHwas 4.2/~c/mgandthis preparationwas 86-90% bound by excess specific antibody. The binding of these two preparations by normal mouse serum did not exceed 5%. The determination of "% antigen bound" values for these two antigens was done in the same way as that already described (1), except that only the radioactivity bound to mouse globulin and precipitated by the rabbit anti-mouse -~-giobulln was counted. This was done by dissolving the precipitates in 0.3 ml of 0.1 N NaOH, after which they were transferred to a dioxane-polyether scintillator solution and counted in a Nuclear-Chicago Mark I liquid scintillation counter.
All the mice used in these studies were bred from the original CBA and C57 inbred lines (1).
R~SULTS

Tke Specificity of Determinant-Specific ControL--The immune response of
CBA and C57 mice to a series of related synthetic polypeptide antigens is summarized in Table II . Branched polymers G-A--L233 10,100 CBA (10) Neg. predpitin pGlu-pDL-ala--plys, tool C57 (10) Neg. precipitin wt 43,500
10 CBA (46) 28 5-60 p(tyr, glu)-pDL-ala--plys C57 (37) 78 55-95 mol wt 232,000 Table II (c) The pattern of response of CBA and C57 mice to this class of antigens is determined almost entirely by the amino acid composition of the side chain termini. With poly(tyr, gin), CBA's are low and C57's are about 10-fold higher (Table II and reference 1); with poly(his,glu), CBA's are high and C57's are very low; and, with poly(phe,giu), the two strains respond well and equally.
This is true for (T, G)-A--L 509 and (T, G)-A--L 210, and is also true for (H, G)-A--L 1201 (see
[In addition to the small numbers of anti-(P, G)-A--L sera in Table II titered with both (P, G)-A--L-223-(Ac)*H and (T, G)-A--L 509A'6I, 6 more CBA and 6 more C57 anti-(P, G)-A--L antisera titered only against (T, G)-A--L 509-~'5I gave results identical with those seen in Table II .] Since (T,G)-A--L 509 and (P,G)-A--L 223 have similar residue molar ratios, it is likely that they have similar charge distributions and a similar distribution of hydrophobic residues. Therefore, the possibility that these different patterns of response reflect differences in response to charge or to hydrophobic areas on the antigen molecule seems unlikely. On the other hand, it seems clear that the different patterns of response are due to the different amino acids (tyrosine, histidine, or phenylalanine) in the antigenic determinant.
(a t) For a single branched antigen in which the sequence of residues in the side chain is polytyr-polyglu-poly-DL-ala-, the pattern of response is the same as that seen with (T, G)-A--L, although 10-f01d lower. The very weak response to this antigen may be due to its low tyroslne content, or to the possibility that this sequence is a "weak" antigenic determinant.
Genetic Analysis of the Response to (H ,G)-A-L in CBA and C57
M/ce.-- Fig. 2 shows the results of immunizing CBA, C57, (CBA X C57) F, and F, X CBA * These determinations were done using 5/A of mouse antiserum and 0.8/~g (T,G)-A--L 509-LS5I, or 0.1 /Jg (H,G)-A-L 1201-(Ac)SH, or 0.1/~g (P,G)-A--L 223-(Ae)aH. This is an excess of (H,G)-A-L on an equimolar basis, but was used due to this preparation's low specific activity.
and FI X C57 mice with I00 ~ag (H,G)-A--L 1201 in complete Freund's adjuvant, followed 5 weeks later by an identical booster dose in aqueous solution. The mice were bled 10 days after receiving the booster dose, and individual sera were tested for their ability to bind (H, G)-A--L 1201-(Ac)aH and (T, G)-A--L 509-n5I: The results given in Fig. 2 are with (H,G) -A--L-(Ac)~-I; the results obtained with (T, G)-A--L 509-n5I are similar but slightly lower.
From these results, it would appear that the differing ability of CBA and C57 mice to make an antibody response to (H,G)-A--L is under genetic control, and that this control is dominant and in all likelihood due to more than one genetic factor, or to one major genetic factor plus an unknown number of modi-tiers. This tentative conclusion is based on the observation that in the Ft X C57 backcross there is not a clear 1:1 Mendelian segregation of C57 and F1 phenotypes. Thus, the genetic control of the immune response to (H, G)-A--L is of the same type as that already described for (T, G)-A--L (1). I
Cross-Reactlon Versus Cross-Stimulation.-- Table II shows extensive crossreactions between anti-(H,G)-A-L and anti-(P,G)-A--L and (T,G)-A--L 509-~5I. A more systematic study of these cross-reactions is seen in Table III , where the ability of individual antisera to bind each of these related antigens is shown (only a few typical antisera of each type are shown). With only a few exceptions, each antiserum had a higher "% antigen bound" value with its immunizing antigen than with the two cross-reacting antigens. The amount of cross-reaction usually exceeded 50 % in all combinations except CBA anti- 
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DISCUSSION
The most striking fact to emerge from these studies is the existence of separate systems of genetic control of the antibody response to different antigenic determlnants carried on the same type of carrier molecule. An integral part of this finding is the very sharp degree of discrhnination between different types of antigenic determinant. In short, the genetic factors controlling the ability to respond to a given antigenic determinant can discriminate clearly between tyrosine, tfistidine, and phenylalanine in the antigenic determinant. This is all the more remarkable in view of the extensive cross-reactions which occur between these antigens and their various antisera, although cross-stimulation of the antibody response does not seem to occur.
The genetic differences affecting the antibody response to (T,G)-A--L and (H, G) -A--L in CBA and C57 mice appear to be of the same type, i.e., dominant, polygenlc, quantitative, and determinant-specific. This does not prove that the genetic factors controlling the two immune responses operate via the same mechanism(s), but it is compatible with this view. As has already been noted, these genetic factors appear to recognize different amino acid compositions, a degree of stereospecificity that is most commonly found in enzymes and in antibodies. It is not possible at this point to know whether the genetic differences in response found between CBA and C57 mice are due to genetic differences in enzymes which "process" the antigen, to genetic differences in the structure of antibodies made against these antigens, or to some alternative mechanism.
SU'M'IWARy
CBA and C57 mice wcrc tested for their ability to make an immune response to a related series of branched, multichain synthetic polypeptide antigens in which the antigenic determinants on the amino termini of the branched side chains were systematically varied. Neither strain responded to the polyglutamic acid determinant. Both strains responded well and equally to the poly(phcnylalanine, glutamic acid) determinants. CBA mice responded poorly, and C57 mice responded wcU to two different antigcns bearing poly(tyrosinc, glutamic acid) determinants. CBA mice responded well, and C57 mice responded poorly to two different antigens bearing poly(histidine, glutamic acid) determinants.
The genetic control of the immune response to (H,G)-A--L appears to be dominant and polygenic, as it has been shown to be for (T, G)-A--L.
The related antigens used in this study show extensive cross-reactions with antisera against other members of the related series. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice. J. Exptl. Med. 122:517.
